|
PCBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40620000002689E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.963850E-01 |
| Normal-vs-Stage2 |
1.220770E-04 |
| Normal-vs-Stage3 |
1.50740000004479E-06 |
| Normal-vs-Stage4 |
5.62949999949325E-07 |
| Stage1-vs-Stage2 |
5.044500E-03 |
| Stage1-vs-Stage3 |
1.165120E-04 |
| Stage1-vs-Stage4 |
6.01069999999204E-05 |
| Stage2-vs-Stage3 |
8.135400E-01 |
| Stage2-vs-Stage4 |
5.214800E-01 |
| Stage3-vs-Stage4 |
6.529400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75040000000215E-05 |
| Normal-vs-AfricanAmerican |
4.42899999997248E-06 |
| Normal-vs-Asian |
2.157600E-01 |
| Caucasian-vs-AfricanAmerican |
1.703780E-02 |
| Caucasian-vs-Asian |
8.216200E-01 |
| AfricanAmerican-vs-Asian |
2.202600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36039999990112E-07 |
| Normal-vs-Female |
2.592000E-02 |
| Male-vs-Female |
4.600000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.819600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.158400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.001070E-04 |
| Normal-vs-Age(81-100Yrs) |
9.743700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.209630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.902170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.764800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.941200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.091600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.441800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.612000E-01 |
| Normal-vs-Grade 2 |
1.740570E-01 |
| Normal-vs-Grade 3 |
1.73786999999592E-05 |
| Normal-vs-Grade 4 |
2.73510103454555E-11 |
| Grade 1-vs-Grade 2 |
4.520600E-01 |
| Grade 1-vs-Grade 3 |
1.680440E-02 |
| Grade 1-vs-Grade 4 |
4.174400E-04 |
| Grade 2-vs-Grade 3 |
3.442000E-03 |
| Grade 2-vs-Grade 4 |
1.86860005246814E-09 |
| Grade 3-vs-Grade 4 |
2.768200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.323800E-01 |
| Normal-vs-ccB subtype |
9.07389718918239E-11 |
| ccA subtype-vs-ccB subtype |
8.79074590898199E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.925000E-03 |
| Normal-vs-N1 |
1.120240E-03 |
| N0-vs-N1 |
3.288000E-02 |
|
|
